Discontinuation report NORPROLAC

Last updated on 2020-12-11 History
Report ID 129605
Drug Identification Number 02223767
Brand name NORPROLAC
Common or Proper name Quinagolide Hydrochloride
Company Name FERRING INC
Market Status MARKETED
Active Ingredient(s) QUINAGOLIDE
Strength(s) 0.075MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 tablets per carton
ATC code G02CB
ATC description OTHER GYNECOLOGICALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-12-02
Actual discontinuation date 2020-12-09
Remaining supply date 2020-12-02
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments NORPROLAC 150 mcg tablets (DIN 02223767) and NORPROLAC starter pack containing 25 mcg (DIN 02223740) and 50 mcg (DIN 02223759) tablets are in stock and available.
Health Canada comments
Contact Address 200 YORKLAND BLVD
TORONTO, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-12-11 French Compare
v3 2020-12-11 English Compare
v2 2020-12-04 French Compare
v1 2020-12-04 English Compare